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Abstract
Background: Tuberculin skin tests (TSTs) are long-established screening methods for tuberculosis (TB). We aimed to
compare agreement between the intradermal Mantoux and multipuncture percutaneous Tine methods and to quantify risk
factors for a positive test result.
Methodology/Principal Findings: 1512 South African children younger than 5 years of age who were investigated for
tuberculosis (TB) during a Bacille Calmette Guerin (BCG) trial were included in this analysis. Children underwent both
Mantoux and Tine tests. A positive test was defined as Mantoux $15 mm or Tine $ Grade 3 for the binary comparison.
Agreement was evaluated using kappa (binary) and weighted kappa (hierarchical). Multivariate regression models identified
independent risk factors for TST positivity. The Mantoux test was positive in 430 children (28.4%) and the Tine test in 496
children (32.8%, p,0.0001), with observed binary agreement 87.3% (kappa 0.70) and hierarchical agreement 85.0%
(weighted kappa 0.66). Among 173 children culture-positive for Mycobacterium tuberculosis, Mantoux was positive in 49.1%
and Tine in 54.9%, p,0.0001 (kappa 0.70). Evidence of digit preference was noted for Mantoux readings at 5 mm threshold
intervals. After adjustment for confounders, a positive culture, suggestive chest radiograph, and proximity of TB contact
were risk factors for a positive test using both TST methods. There were no independent associations between ethnicity,
gender, age, or over-crowding, and TST result.
Conclusions/Significance: The Tine test demonstrated a higher positive test rate than the Mantoux, with substantial
agreement between TST methods among young BCG-vaccinated children. TB disease and exposure factors, but not
demographic variables, were independent risk factors for a positive result using either test method. These findings suggest
that the Tine might be a useful screening tool for childhood TB in resource-limited countries.
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Introduction
Tuberculin skin tests (TSTs) are long-established screening
methods for tuberculosis (TB) infection that detect the cell-mediated
response to inoculation of a mixture of Mycobacterium tuberculosis
antigens, some of which are common to bacille Calmette-Guerin
(BCG) and non-tuberculous mycobacteria (NTM)[1,2]. Tradition-
ally, TSTs have also formed part of the decision-making pathway
for the diagnosis of childhood TB disease[3]. In recent years, there
has been intense research interest in diagnosis of latent TB infection
by quantitative interferon-gamma release assays (IGRAs), which
may offer rapid turnaround and greater specificity[4]. Authorities in
some developed countries have recommended that the TST be
replaced completely by the IGRA, although the evidence
supporting the use of IGRAs for diagnosis of active TB disease in
young children is less than compelling[1,5,6,7]. Indeed, IGRAs
have not yet been incorporated into TB control programmes in
high-burden developing countries where IGRA sensitivity may be
lower, and where healthcare resources and laboratory capacity are
most limited[8]. It follows that evidence to guide the use and
interpretation of TSTs remains relevant to clinicians and public
health programmes in high-burden regions.
The intradermal Mantoux test was adopted as de facto standard
of care in many developed countries, based on the high rate of
false negative results in studies using the percutaneous multi-
puncture Tine method during the 1970’s and 1980’s[9,10,11,12].
For example, Lunn and Johnson reported for the British Thoracic
Association that the Tine test was unsuitable for epidemiological
use, because of the high proportion of negative results in subjects
with a positive Mantoux[11]. Although these findings generated
controversy and were contradicted by several studies since 1965,
which recommended the Tine test for use in resource-limited
settings, multi-puncture TST methods fell into disre-
pute[2,13,14,15,16]. This may be unfortunate, since the dispos-
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method, including rapid application; less wastage; lower unit cost;
and lower operator skill level. These potential advantages are
counter-balanced by inconsistent delivery of tuberculin by multi-
puncture Tine tools, and whereas grading of Tine induration is
semi-quantitative, the Mantoux allows more precise measure-
ment[17]. Nevertheless, the advantage of precise measurement of
the Mantoux induration is inevitably sacrificed when the test result
is categorized as positive or negative, so that it can be interpreted
and acted upon by clinicians. Threshold values of 5 mm, 10 mm,
and 15 mm have all been used by the American Thoracic Society
(ATS), Centers for Disease Control and Prevention (CDC), South
African National Tuberculosis Control Programme, and World
Health Organization (WHO) for categorical interpretation of the
Mantoux result in various TB risk categories and TB prevalence
settings[18,19,20,21]. Although these threshold values may have
been selected using the best available evidence, it must be
acknowledged that the actual values may have little biological
meaning. These problems are amplified by the fact that the
traditional threshold values are commonly associated with digit
preference, which may result in misclassification errors[22].
It is also accepted that both the Mantoux and Tine methods
may be subject to factors causing false positive or negative results,
including BCG vaccination, NTM exposure, malnutrition, and
human immunodeficiency virus (HIV) infection[23]. Several
studies have attempted to identify factors associated with TST
positivity in order to optimize contact tracing strategies, but the
majority of studies have either been small scale, or performed
among older children and adults, in developed countries with low
TB prevalence, using only the Mantoux method (Table 1)
([24,25,26,27,28,29,30,31,32,33,34,35,36,37]. Few large studies
have included young children, in whom the risk of TB disease is
highest, particularly in high prevalence regions of sub-Saharan
Africa, and there are no such studies that directly compare
intradermal Mantoux and percutaneous multi-puncture Tine
methods in the same paediatric population[29,30,37]. It was our
primary hypothesis that Mantoux and Tine methods would
demonstrate moderate agreement in such a study population.
Second, we postulated that positive results for both tests would be
associated with proximity of exposure to TB contact, and with
microbiological and radiological features of TB disease. We
present a direct comparison of the intradermal Mantoux and
percutaneous multipuncture Tine tests, in which independent risk
factors for test positivity are examined in a single study group of
young BCG-vaccinated children, in a South African community
with very high TB incidence.
Methods
This analysis is based on data collected during a BCG vaccine
trial in a rural area near Cape Town, South Africa, during 2001–
2006 (Clinical Trials identifier: NCT00242047)[38]. A total of
11680 healthy newborns were followed up for a minimum of 2
years (maximum 4.7) after vaccination with Tokyo 172 BCG. The
incidence of TB in this region in 2006 was reported as 940 per 100
000 population, and .3000 per 100 000 among children younger
than 2 years of age[38,39,40]. All children with a TB contact, or
symptoms compatible with TB, were identified by community
surveillance and the 1869 children who subsequently underwent
standardized TB case investigation were eligible for inclusion in
this analysis. HIV infection status was determined by rapid
antibody test and confirmatory Polymerase Chain Reaction
(PCR). Chest radiographs were reviewed by a panel of expert
paediatricians for compatibility with a diagnosis of TB. Two
consecutive, early morning, paired gastric lavages and induced
sputa were obtained for auramine staining and culture of
Mycobacterium tuberculosis as previously described[41]. The trial
was approved by the University of Cape Town Research Ethics
Committee (UCTREC 271/2000) and written informed consent
was obtained from parents/guardians.
Children underwent simultaneous Tine and Mantoux tubercu-
lin skin tests. The disposable Tine disc (Lederle Laboratories,
Philadelphia, USA) was applied percutaneously to the right
forearm and 2 units of purified tuberculin protein derivative
(PPD) (Statens Serum Institut, Copenhagen, Denmark) were
injected intradermally to the left forearm. Due to a temporary
stock shortage, some children did not receive a Tine test and
therefore paired results were available for 1512 of 1869 children
(80.9%). TSTs were read at 48–72 hours and readers were not
blinded. Each Tine and Mantoux result was classified both
according to a categorical hierarchy, and according to a binary
(positive/negative) category, using an approach described previ-
ously[12,13]. The Tine result was ranked in 5 ascending categories
described previously: Grade 0 (no indurated papules); Grade 1
(induration of one or more discrete papules); Grade 2 (confluent
induration of two or more papules); Grade 3 (confluent plateau
induration of all papules); and Grade 4 (confluent blister-
ing)[12,13,14,15]. Similarly, the Mantoux result was ranked in 5
ascending categories (0–4 mm; 5–9 mm; 10–14 mm; 15–19 mm;
and $20 mm), based upon historical comparisons of Mantoux
and Tine tests; traditional threshold values recommended by the
ATS, CDC, and WHO; and recent data suggesting a higher cut-
off for BCG-vaccinated infants [12,13,14,15,18,19,20]. A strongly
positive skin test reaction was used to define the trial end-point
(diagnosis of TB disease among very young BCG-vaccinated
children in a high prevalence area), as per prevailing WHO and
South African national TB programme guidelines[18,21,42].
Therefore, the per protocol definition of a positive TST result was
confluent plateau induration of all Tine papules and/or blistering
(Grade 3 or 4 reaction), or Mantoux induration measuring
$15 mm in the horizontal diameter. Alternative lower threshold
values (Tine Grade 2 reaction and Mantoux induration $10 mm)
and lower hierarchical Mantoux categories were examined in
sensitivity analyses. Kappa statistics were generated to examine
binary (positive/negative) agreement between TST methods and
weighted kappa statistics were calculated to examine categorical
hierarchical agreement. The strength of agreement was defined as
follows: kappa 0–0.2=slight; 0.2–0.4=fair; 0.4–0.6=moderate;
0.6–0.8=substantial; and 0.8–1.0=almost perfect agreement[43].
Continuous data are presented as median and interquartile
range (IQR). Categorical data are presented as n (%). Crude
associations between positive TST and demographic, TB disease,
and TB exposure factors were examined using the Mann-Whitney
test for non-parametric continuous data and the McNemar’s or
chi-squared tests for categorical data. Separate multivariate logistic
regression models were built to identify independent risk factors
for positive (binary) outcomes for the Mantoux and Tine tests.
Manual stepwise nested model selection was used to identify the
variables for inclusion in the final logistic model. After adjusting
for potential confounding variables, odds ratios (95% confidence
intervals) were calculated with positive Mantoux or Tine test as the
outcome variable. All statistical analyses were performed using
STATA Version 10 (StataCorp, College Station, Texas).
Results
The study population (n=1512) included 764 (50.5%) males and
748 (49.5%) females, median age 14.5 months (IQR 13.7 months), and
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.2 weeks was reported in 645 (42.7%) and fever was reported in 583
children (38.6%). The median household size was 6 members. A TB
contact was reported outside of the household in 298 children (19.7%),
inside the household, but excluding the child’s mother, in 551 children
(36.4%), and a maternal TB contact was reported in 144 children
(9.5%). HIV ELISA was positive in 47 children, of whom 30 (2.0%)
were confirmed HIV infected. The chest radiograph was suggestive of
TB disease in 298 (19.7%) and M. tuberculosis was cultured in 173
children (11.4%).
The Mantoux test was positive at the 15 mm threshold in 430 of
1512 children (28.4%) and the Tine test was positive at the Grade 3
threshold in 496 children (32.8%), (p,0.0001). The Mantoux detected
77% of 559 children with a positive test result by either TST method
(37.0%), compared to the Tine which detected 89% (p,0.001).
Conversely, 59% of children had a Mantoux reaction ,5m m
Table 1. Studies reporting independent (adjusted) risk factors for a positive TST among child contacts of TB cases.
Author Test Population Region Size (n) Positive risk factors Negative risk factors
Bailey[24] Mantoux Adults + children North America n=3528 Case AFB+ smear Sex female
Case with CXR cavitation Age,15 years
Race other than white
Total hours exposed
Besser[26] Mantoux Children North America n=159 BCG vaccinated
Previous TST ,12 months ago
Carvalho[36] Mantoux Adults + children Europe n=360 Household size
Case HIV infected
Older age
Lienhardt[29] Mantoux Children West Africa n=285 Family member with positive TST Duration of cough ,10 weeks
Household proximity to case
Household size
Lobato[34] Mantoux Children North America n=953 Foreign travel
Foreign visitor
Sex female
Rathi[31] Mantoux Adults + children South Asia n=385 Older age
Sleeping site proximity to case
Case AFB+ smear
BCG scar
Bener[35] Mantoux Children Central Asia n=785 Older age
Household number of rooms
BCG vaccinated
Gustafson[37] Mantoux Adults + children West Africa n=1980 Older age Tested in rainy season
Household case
Sleeping site proximity to case
Sex female
BCG scar
Musoke[30] Mantoux Children East Africa n=365 Case AFB+ smear
Saiman[32] Mantoux Children North America n=288 Adult case Previous negative TST
Family member with positive TST
Foreign birth
Foreign travel
Froehlich[27] Mantoux Children North America n=31926 BCG vaccinated
Ethnicity Asian/Hispanic
Family member with positive TST
Foreign birth
Foreign travel
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(p,0.001). The distribution plot of the Mantoux induration diameter
suggests that reader digit preference occurred at the 5 mm, 10 mm,
15 mm, and 20 mm threshold values (Figure 1).
Observed agreement for comparison of binary positive/negative
TST outcomes was 87.3%, with unweighted kappa=0.70
(Table 2).
Observed agreement for hierarchical TST outcomes was 85%,
with weighted kappa=0.66 (Table 3).
Sub-Group Analysis
Among 173 children culture-positive for Mycobacterium tuberculo-
sis, the TST was positive by at least one method in 103 cases
(59.5%). The Mantoux was positive in 85 children (49.1%) and the
Tine in 95 children (54.9%), p,0.0001, with 85.0% observed
agreement and kappa=0.70. However, observed agreement for
hierarchical categories was 56.7% (kappa=0.42), with the
predominant source of disagreement arising from cases in which
the Tine result lay in a higher category than the Mantoux result
(data not shown). Fifty-nine children (34.1%) showed a Mantoux
reaction ,5 mm diameter, compared to 41 children (23.7%) with
a Grade 0 Tine reaction (p,0.0001).
Univariate Analysis
The odds of a positive Mantoux test were increased by
demographic factors, including mixed ancestry and increasing
age; TB disease factors, including suggestive chest radiograph,
culture of M. tuberculosis, previous TB treatment; other factors, such
as previous anthelmintic treatment; and TB exposure factors,
including a household TB contact (other than mother), as well as a
maternal TB contact. Wheezing and HIV infection were both
associated with a negative Mantoux test. The factors of mixed
ancestry, female gender, increasing age, suggestive chest radio-
graph, culture of M. tuberculosis, previous TB treatment, household
TB contact, and maternal TB contact, were risk factors for a
positive Tine test. HIV infection, fever, and increasing sibling
numbers, were also associated with a negative Tine test (Table 4).
Multivariate Analysis
In the multivariate analysis, the adjusted odds of a positive
Mantoux test were increased by suggestive chest radiograph,
culture of M. tuberculosis, previous anthelmintic treatment, and
three categories of TB contact (outside the household, inside the
household excluding mother, and maternal TB contact, which
demonstrated the strongest association). Weight for height Z-score
between -1 and zero, compared to a more severe score, was
associated with a negative Mantoux. Suggestive chest radiograph,
culture of M. tuberculosis, the same three categories of TB contact,
and previous TB treatment, were independent risk factors for a
positive Tine test. Weight for height Z-score between -1 and zero
was also associated with a negative Tine test, as was the presence
of fever, and HIV infection (Table 5).
Sensitivity Analysis
The effect of lowering the TST threshold values was compared
to the per protocol results above. Lowering the threshold for a
positive test result to 10 mm Mantoux and Grade 2 Tine yielded
similar observed agreement (86.4%) and unweighted kappa=0.72.
Lowering the Mantoux hierarchy ranking by one category, that is
Mantoux 0 mm; 1–4 mm; 5–9 mm; 10–14 mm; and $15 mm,
compared to Tine Grades 0–4, also demonstrated similar observed
agreement (84.4%) and weighted kappa=0.64. In the multivariate
model, lowering the threshold for positive Mantoux to 10 mm
yielded a similar set of variables associated with a positive test
result, with the exception that previous anthelmintic treatment
(risk factor) exited the model and previous TB treatment (risk
factor) and wheezing (protective factor) entered the model.
Discussion
We have shown in this large study of young children with
suspected tuberculosis that there is substantial agreement between
the Mantoux and Tine methods, both for the binary comparison
and for hierarchical categories of increasing skin test reactivity.
This level of agreement occurred in the presence of evidence of
reader digit preference for Mantoux values occurring at 5 mm
threshold intervals and similar findings were obtained in sensitivity
analyses using alternative threshold values for a positive test.
Further, even though a relatively high positive test threshold was
defined, 37% of all children, and 59% of culture-positive children,
had a positive TST result by at least one method. In contrast to
several previous studies, the proportion of children with a positive
Tine was significantly greater than the proportion with a positive
Mantoux, and the Tine had a lower rate of minimally reactive/
unreactive tests than the Mantoux method[9,10,11,12]. These
findings also held true for the sub-group of children with a positive
culture of M. tuberculosis.
There are no large studies that describe direct comparison of
Mantoux and Tine results in the last two decades, either among
children or adults, although earlier adult studies reported high
rates of false-negative Tine results among participants who were
Mantoux positive[9,10,11,12]. For example, the influential study
Figure 1. Histogram showing distribution of Mantoux indura-
tion diameter (n=1512) with evidence of reader digit prefer-
ence at the 5 mm, 10 mm, 15 mm, and 20 mm values.
doi:10.1371/journal.pone.0008085.g001
Table 2. Agreement between Mantoux and Tine tests for
binary comparisons (positive/negative test) among 1512
children (kappa=0.70).
Test Tine Positive Tine Negative Total
Mantoux
Positive
n=367 (24.3%) n=63 (4.2%) n=430 (28.4%)
Mantoux
Negative
n=129 (8.5%) n=953 (63.0%) n=1082 (71.6%)
Total n=496 (32.8%) n=1016 (67.2%) n=1512 (100%)
doi:10.1371/journal.pone.0008085.t002
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positive rate of 59%, compared to a Tine positive rate of 3.9%,
with 40% of all readings Tine negative and Mantoux positive[11].
Clearly, categorical agreement and positive test rate do not
measure the accuracy of either test since, in the absence of a gold
standard for latent tuberculosis infection, a positive TST may
reflect BCG or NTM exposure. However, our findings among M.
tuberculosis culture-positive children imply that the Tine test may
have equivalent or higher detection rates for mycobacterial
antigen exposure among young BCG-vaccinated children in this
Table 3. Agreement between Mantoux and Tine tests for ordered categorical comparisons (Mantoux ,5 mm, $5 to 10 mm, $10
to 15 mm, $15 to 20 mm, $20 mm, and Tine Grades 0–4), among n=1512 children (weighted kappa=0.66).
Test Tine (Grade) 01234T o t a l
Mantoux (mm)
0–4 n=600 (39.7%) n=169 (11.2%) n=81 (5.4%) n=27 (1.8%) n=15 (1.0%) n=892 (59.0%)
5–9 n=12 (0.8%) n=11 (0.7%) n=28 (1.9%) n=11 (0.7%) n=6 (0.4%) n=68 (4.5%)
10–14 n=2 (0.1%) n=12 (0.8%) n=38 (2.5%) n=32 (2.1%) n=38 (2.5%) n=122 (8.1%)
15–20 n=5 (0.3%) n=12 (0.8%) n=27 (1.8%) n=40 (2.7%) n=89 (5.9%) n=173 (11.4%)
$20 n=2 (0.1%) n=5 (0.3%) n=12 (0.8%) n=30 (2.0%) n=208 (13.8%) n=257 (17.0%)
Total n=621 (41.1%) n=209 (13.82%) n=186 (12.3%) n=140 (9.26%) n=356 (23.55%) n=1512 (100%)
doi:10.1371/journal.pone.0008085.t003
Table 4. Risk factors (odds ratios and 95% confidence intervals, CI) associated with a positive Mantoux or Tine test (univariate
analysis) among n=1512 children investigated for TB.
Mantoux OR (95% CI) Tine OR (95%CI)
Demographic factors
Mixed ancestry 1.64 (1.16–2.30)) 1.74 (1.25–2.41)
Gender female 1.25 (0.99–1.56) 1.68 (1.35–2.09)
Age (months) 1.01 (1.00–1.03) 0.99 (0.98–1.00)
Weight for height z-score 0.94 (0.87–1.02) 0.98 (0.92–1.05)
Height for age z-score 1.05 (0.98–1.13) 0.94 (0.87–1.02)
Weight for age z-score 0.99 (0.92–1.09) 0.95 (0.89–1.02)
TB disease factors
Suggestive chest radiograph 2.28 (1.76–2.95) 1.82 (1.39–2.39)
Previous TB treatment 2.15 (1.69–2.71) 1.65 (1.29–2.11)
Culture of M.Tuberculosis 2.49 (1.78–3.48) 2.83 (1.99–4.04)
AFB smear positive 0.31 (0.03–1.32) 4.11 (0.59–45.5)
Wheezing 0.65 (0.52–0.82) 0.85 (0.68–1.07)
Cough .2 weeks 0.19 (0.68–1.09) 0.92 (0.75–1.14)
Fever 0.81 (0.64–1.01) 0.65 (0.51–0.82)
Night sweats 0.85 (0.68–1.08) 0.98 (0.79–1.21)
Other factors
Previous anthelmintic treatment 1.36 (1.07–1.73) 0.97 (0.76–1.24)
HIV infection 0.08 (0.00–0.51) 0.15 (0.02–0.62)
TB exposure factors
Overcrowding
Number of siblings 0.96 (0.87–1.05) 0.93 (0.86–1.00)
Number of household members 1.02 (0.98–1.06) 1.03 (0.99–1.06)
TB contact
None 1.00 1.00
Outside household 0.85 (0.64–1.12) 0.91 (0.68–1.19)
Inside household (excluding mother) 1.5 (1.2–1.87) 1.45 (1.15–1.82)
Mother 2.94 (2.08–4.13) 3.3 (2.29–4.77)
doi:10.1371/journal.pone.0008085.t004
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wastage, and operator time, as well as the lesser skill level needed,
it would be reasonable to recommend the multi-puncture Tine as
a screening tool for childhood TB in developing regions with
limited funds, equipment, and a shortage of health care personnel.
We have shown in a multivariate analysis that the odds of a
positive Mantoux among children with suspected TB were
increased if the chest radiograph were suggestive of pulmonary
TB disease, and if M. tuberculosis were cultured from gastric lavage
fluid or from induced sputum. This would be expected among
children with prior TB infection that progressed to active disease,
and supports the inclusion of the Mantoux test result in the
diagnostic decision-making pathway for childhood TB, even in
high TB prevalence areas. All three categories of TB contact were
independent risk factors for a positive Mantoux, with the
magnitude of the association increasing in proportion to the
proximity of contact, and with maternal contact being the
strongest risk factor. These findings are consistent with increased
household exposure to family TB contacts among younger
children who spend the majority of time with their mothers.
These data also emphasize the importance of contact tracing and
LTBI prophylaxis for household contacts of smear positive adults
in national TB control programmes. Many of the risk factors for a
positive Mantoux test were common to the Tine test, including a
suggestive chest radiograph, culture of M. tuberculosis, and the same
three categories of TB contact.
The presence of fever and HIV infection were both indepen-
dently associated with a negative Tine test, although these
variables did not enter the final Mantoux regression model. HIV
infected children might be expected to have less skin test reactivity
on the basis of immune-suppression. However, our finding of a
negative association between HIV infection and the Tine test
result is in contrast to studies in the USA and Uganda[30,32].
Fever is a feature of TB disease, but the fact that fever was
associated with a negative Tine test might be explained if fever in
the children being investigated was primarily on the basis of
infections other than TB, or if children with fever were more
severely ill. We have shown that a weight-for-height Z-score
between -1 and zero was protective against positive Mantoux and
Tine tests, compared to more severe Z-scores, although others
have reported no independent relationship between TST result
and nutritional status[29,30]. It is possible that in our study, more
severe weight-for-height Z-scores might have been associated with
a positive TST in the setting of active TB disease.
Several demographic factors associated with positive Mantoux
and Tine tests in the univariate analysis, such as ethnicity, gender,
and age, were excluded from the multivariate regression model as
dependant co-variables, suggesting that TST positivity is primarily
related to TB exposure rather than demography. Interpretation of
the literature is complicated by the fact that studies of risk factors
for TST positivity have been conducted in populations with very
different demographic, public health, and clinical characteris-
tics[24,25,27,30,32,33,35,36,37]. For example, in our study there
were no independent associations between TST result and
measures of overcrowding, even though households were relatively
large, similar to findings in the UAE and Uganda, but in contrast
to a study in Brazil[30,35,36].
This study has several notable limitations. All children had been
BCG-vaccinated and lived in the same high TB prevalence area,
so we were not able to examine potential associations between
these factors and TST positivity. Similarly, the findings apply only
to young children under the age of five years, who form the age
group with the greatest relative burden of TB disease. It is also not
possible to assess the performance of either TST among those
children with a clinical diagnosis of TB from whom M. tuberculosis
was not cultured, since the TST result formed part of this
diagnostic algorithm[38].
The per protocol definition of TST positivity was designed to aid
diagnosis of TB disease among young BCG-vaccinated children, in
accordance with the prevailing national and international
guidelines[18,21,42]. This threshold level is higher than that
currently advocated by some authorities, although it has recently
been suggested that the optimal threshold for a positive Mantoux
in BCG-vaccinated infants may be even greater[44,45,46]. It
might also be argued that use of a threshold to dichotomize
positive and negative tests ignores the value of precise quantitative
measurements offered by the Mantoux method, resulting in bias
towards the semi-quantitative Tine test. However, we suggest that
this approach mirrors clinical practice, in that clinical manage-
ment decisions are likely to be made on the basis of a positive or
negative TST result. It is true that much of the inherent
complexity of precise measurement is lost when the Mantoux test
result is categorized as positive or negative for clinical purposes.
Threshold values of 5 mm, 10 mm, and 15 mm have all been used
Table 5. Independent risk factors (odds ratios, OR, and 95% confidence intervals, CI) associated with a positive Mantoux or Tine
test among n=1512 children investigated for TB (multivariate logistic regression model).
Mantoux test positive Tine test positive
OR 95%CI p OR 95%CI p
Weight for height Z-score (21,0) 0.71 (0.53–0.95) 0.02 0.64 (0.48–0.86) ,0.0001
Suggestive chest radiograph 2.31 (1.71–3.11) ,0.0001 2.06 (1.51–2.81) ,0.0001
Previous TB treatment ------ ------ 1.56 (1.17–2.09) ,0.0001
Culture of M. tuberculosis 2.19 (1.49–3.24) ,0.0001 2.47 (1.65–3.69) ,0.0001
Fever ------ ------ 0.70 (0.53–0.93) ,0.0001
Previous anthelmintic treatment 1.41 (1.06–1.87) 0.02 ---- -----
HIV infection ------ ------ 0.09 (0.01–0.74) 0.02
TB contact outside household 1.86 (1.26–2.72) ,0.0001 1.98 (1.37–2.88) ,0.0001
TB contact inside household (excluding mother) 2.53 (1.81–3.53) ,0.0001 2.28 (1.64–3.18) ,0.0001
TB contact mother 5.43 (3.46–8.53) ,0.0001 5.47 (3.39–8.81) ,0.0001
doi:10.1371/journal.pone.0008085.t005
Comparison of Mantoux and Tine
PLoS ONE | www.plosone.org 6 November 2009 | Volume 4 | Issue 11 | e8085by the ATS, CDC, South African National Tuberculosis Control
Programme, and WHO for categorical interpretation of the
Mantoux result in various TB risk categories and TB prevalence
settings, although it must be acknowledged that the actual values
may have little biological meaning[18,19,20,21]. Inaccuracy of the
Mantoux method may be falsely exaggerated by the fact that the
traditional threshold values are commonly associated with digit
preference, as we have demonstrated, which may result in
misclassification errors that are difficult to correct for individual
readings[22,47]. However, although digit preference tends to
undercount both those values immediately above and immediately
below the preferred threshold values, the practical outcome of digit
preference is usually misclassification into higher, rather than
lower, Mantoux categories (eg. $5 mm; $10 mm; and
$15 mm)[22]. Therefore, although it is possible that the
substantial agreement between categorical Mantoux and categor-
ical Tine results is influenced in some way by digit preference, this
factor does not explain why the Tine test demonstrated a
significantly higher positive test rate than the Mantoux, since the
opposite observation would have been expected.
Since we lack a diagnostic gold standard for latent tuberculosis
infection, we are unable to measure the accuracy of either TST
method for this purpose, and we acknowledge that the higher
positive Tine rate might reflect BCG or NTM exposure. The
limited sensitivity of the Mantoux among culture-positive children
(49%) may be due, in part, to operator error in the intradermal
administration of tuberculin, as well as the suppressive effect of TB
disease on cell-mediated immunity[4]. Therefore, although we
recommend the Tine as a suitable screening tool in developing
regions, further comparative studies would be needed before the
Tine method could be suggested for definitive diagnosis of
childhood TB disease. These recommendations might appear
retrogressive, given the current research interest in IGRAs[4].
However, the effect of limited healthcare resources on the reality
of TB control in high-burden countries is illustrated by the fact
that, until recently, even Mantoux testing has not been available in
some parts of East Africa[48]. It is likely to be several years before
the IGRA might replace tuberculin skin testing in regions where
childhood TB is most prevalent[1]
In summary, we have shown in a large study of BCG-vaccinated
infants and children who were investigated for TB in a high
prevalence area that the Tine method has a higher positive test
rate than the Mantoux, both overall and among children who
were culture-positive for M. tuberculosis, with substantial agreement
between TSTs for binary and hierarchical comparisons. This level
of agreement occurred in the presence of evidence of reader digit
preference in recording the Mantoux diameter. Multivariate
models showed that independent risk factors for both Tine and
Mantoux tests include TB disease factors, such as a suggestive
chest radiograph or culture of M. tuberculosis, and TB exposure
factors, with maternal TB contact most strongly associated with
the risk of a positive TST. Ethnicity, age, gender, and measures of
overcrowding were not independent predictors of the TST result.
In contrast to previous adult studies, these data suggest that the
Tine may be a reasonable alternative to the Mantoux method as a
screening tool for childhood TB in resource-limited, high-burden
areas, or in settings where convenience and ease of use are major
considerations[9,10,11,12].
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